Analyst firms · Mizuho · ARQT
Mizuho ARQT price target and rating history
Arcutis Biotherapeutics Inc. (ARQT) · Health Care
Mizuho rates Arcutis Biotherapeutics Inc. (ARQT) Buy with a $8 price target, as of its latest action on Jan 3, 2024. It has published 3 rating actions on ARQT since June 2021, including 1 upgrade and 1 downgrade.
- Current rating
- Buy
- Price target
- $8
- Median target, all firms
- Too few
- Actions on ARQT
- 3
Mizuho price target on ARQT
Every Mizuho rating on ARQT
- Jan 3, 2024
- Oct 26, 2023
- Jun 30, 2021
Questions about Mizuho and ARQT
- What is Mizuho's price target for ARQT?
- Mizuho's latest stated price target for Arcutis Biotherapeutics Inc. (ARQT) is $8, from its action on Jan 3, 2024.
- What is Mizuho's rating on ARQT?
- Mizuho rates ARQT Buy, a bullish rating, as of Jan 3, 2024.
- When did Mizuho last change its view on ARQT?
- On Jan 3, 2024, Mizuho upgrades to Buy from Neutral, price target $4 to $8.
More ARQT rating histories
All Mizuho ratingsARQT news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.